Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Schmid

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
JTO Clinical and Research Reports|November 20, 2024
Identifying Novel Germline Mutations and Copy Number Variations in Patients With SCLCSami Ul Haq, Gregory Downs, Luna Jia Zhan, et al.
Therapeutic Advances in Medical Oncology|October 30, 2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastasesMaisam Makarem, Tuan Hoang, Mitchell J Elliott, et al.
Clinical Lung Cancer|September 17, 2021
Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral CentreSabine Schmid, Luna Zhan, Kristen Dietrich, et al.
Esophagus : Official Journal of the Japan Esophageal Society|January 11, 2023
Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinomaUlf Zeuge, Aline F Fares, Joelle Soriano, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2022
Treatment patterns and outcomes in early-stage ALK-rearranged non-small cell lung cancerSabine Schmid, Miguel Garcia, Sierra Cheng, et al.
Clinical Lung Cancer|June 2, 2024
Immediate Versus Deferred Systemic Therapy in Patients With MesotheliomaSabine Schmid, Luna Zhan, Miguel Garcia, et al.
Iscience|November 25, 2022
Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtractionSami Ul Haq, Sabine Schmid, Mansi K Aparnathi, et al.
Heliyon|September 19, 2024
Outcomes with non-small cell lung cancer and brain-only metastasisSabine Schmid, Miguel Garcia, Luna Zhan, et al.
Lung Cancer (Amsterdam, Netherlands)|November 11, 2025
First-line immunotherapy ± chemotherapy with or without upfront stereotactic radiotherapy (SRT) in patients with Non-Small cell lung cancer (NSCLC) with asymptomatic brain metastasesLorenz Frehner, Sämi Schär, Stefanie Hayoz, et al.
Clinical Lung Cancer|October 21, 2022
Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung CancerSabine Schmid, Sierra Cheng, Simren Chotai, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
JTO Clinical and Research Reports|November 20, 2024
Identifying Novel Germline Mutations and Copy Number Variations in Patients With SCLCSami Ul Haq, Gregory Downs, Luna Jia Zhan, et al.
Therapeutic Advances in Medical Oncology|October 30, 2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastasesMaisam Makarem, Tuan Hoang, Mitchell J Elliott, et al.
Clinical Lung Cancer|September 17, 2021
Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral CentreSabine Schmid, Luna Zhan, Kristen Dietrich, et al.
Esophagus : Official Journal of the Japan Esophageal Society|January 11, 2023
Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinomaUlf Zeuge, Aline F Fares, Joelle Soriano, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2022
Treatment patterns and outcomes in early-stage ALK-rearranged non-small cell lung cancerSabine Schmid, Miguel Garcia, Sierra Cheng, et al.
Clinical Lung Cancer|June 2, 2024
Immediate Versus Deferred Systemic Therapy in Patients With MesotheliomaSabine Schmid, Luna Zhan, Miguel Garcia, et al.
Iscience|November 25, 2022
Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtractionSami Ul Haq, Sabine Schmid, Mansi K Aparnathi, et al.
Heliyon|September 19, 2024
Outcomes with non-small cell lung cancer and brain-only metastasisSabine Schmid, Miguel Garcia, Luna Zhan, et al.
Lung Cancer (Amsterdam, Netherlands)|November 11, 2025
First-line immunotherapy ± chemotherapy with or without upfront stereotactic radiotherapy (SRT) in patients with Non-Small cell lung cancer (NSCLC) with asymptomatic brain metastasesLorenz Frehner, Sämi Schär, Stefanie Hayoz, et al.
Clinical Lung Cancer|October 21, 2022
Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung CancerSabine Schmid, Sierra Cheng, Simren Chotai, et al.
Pageof 7